Decibel Therapeutics, Inc. — Form D
Decibel Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2015-10-27. The offering totals $52.0M, of which $8.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-10-27
- Form: D
- Accession: 0001656536-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $52.0M
- Amount sold: $8.0M
- Remaining: $44.0M
- Investors: 2
- Date of first sale: 2015-10-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-250116
Issuer
- Name: Decibel Therapeutics, Inc.
- CIK: 0001656536
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 1325 BOYLSTON STREET, BOSTON, MA, 02215
- Phone: 617-370-8701
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Jens Eckstein | Director | Cambridge, MA |
| Craig Muir | Director | East Kilbride, X0 |
| Michael Solomon | Executive Officer | Ross, CA |
| Kevin Starr | Executive Officer | Cambridge, MA |
| Anthony A Philippakis | Director | Boston, MA |
| Peter A Thompson | Director | New York, NY |
| Christine A Poon | Director | Newark, NJ |
| Elisabeth Leiderman | Executive Officer | Boston, MA |
| Neil A Exter | Director | Boston, MA |
| Laurence Reid | Director | Boston, MA |
| Laurence Reid | Executive Officer | Boston, MA |
| Kevin Starr | Director | Cambridge, MA |
| STEVEN H HOLTZMAN | Director | CAMBRIDGE, MA |
| STEVEN H HOLTZMAN | Executive Officer | CAMBRIDGE, MA |
| George H Scangos | Director | Cambridge, MA |
| Jeffrey H Jonas | Director | Cambridge, MA |
| Roger H Brown | Director | Cambridge, MA |
| Craig H Muir | Director | Cambridge, MA |
| John J Keilty | Executive Officer | Cambridge, MA |
| Troy H Brennan | Director | Cambridge, MA |
| Jens H Eckstein | Director | Cambridge, MA |
Other filings by this issuer (2)
More